Similar articles

• Use of linezolid in children. Introduction.

  Kaplan SL. Kaplan SL. Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S151-2. doi: 10.1097/01.inf.0000086953.15453.15. Pediatr Infect Dis J. 2003. PMID: 14520139 No abstract available.
• Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.

  Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Jantausch BA, et al. Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S164-71. doi: 10.1097/01.inf.0000086956.45566.55. Pediatr Infect Dis J. 2003. PMID: 14520142 Clinical Trial.
• [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].

  Jankowski A, Stefanik W. Jankowski A, et al. Wiad Lek. 2006;59(9-10):727-31. Wiad Lek. 2006. PMID: 17338140 Review. Polish.
• Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.

  Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Deville JG, et al. Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S158-63. doi: 10.1097/01.inf.0000086955.93702.c7. Pediatr Infect Dis J. 2003. PMID: 14520141 Clinical Trial.
• [Linezolid, an agent from a new class of antibiotics].

  Kuijper EJ, Schippers EF, Bernards AT. Kuijper EJ, et al. Ned Tijdschr Geneeskd. 2004 Aug 7;148(32):1577-81. Ned Tijdschr Geneeskd. 2004. PMID: 15382556 Review. Dutch.